Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Journal of Clinical Lipidology|July 28, 2012
The high-dose rosuvastatin once weekly study (the HD-ROWS)James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
Clinical Therapeutics|September 28, 2023
Atherosclerotic Cardiovascular Disease in Women: Providing Protection With Lipid-altering AgentsMegan Hiles, Ashley Simmons, Daniel Hilleman, et al.
Lipids|July 9, 2011
Modified-policosanol does not reduce plasma lipoproteins in hyperlipidemic patients when used alone or in combination with statin therapyJames M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The Annals of Pharmacotherapy|November 19, 2009
Does simvastatin cause more myotoxicity compared with other statins?James M Backes, Patricia A Howard, Janelle F Ruisinger, et al.
Pharmacotherapy|February 24, 2007
Fibrates: what have we learned in the past 40 years?James M Backes, Cheryl A Gibson, Janelle F Ruisinger, et al.
The American Journal of Cardiology|January 27, 2009
Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intoleranceJanelle F Ruisinger, James M Backes, Cheryl A Gibson, et al.
Pharmacotherapy|April 28, 2007
Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratioTammy Burns, Stephanie R Maciejewski, William R Hamilton, et al.
The American Journal of Cardiology|May 25, 2010
Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4Patrick M Moriarty, James P Luyendyk, Cheryl A Gibson, et al.
BMJ Case Reports|October 16, 2015
Hypertriglyceridaemia unresponsive to multiple treatmentsJames M Backes, Thomas D Dayspring, Daniel M Hoefner, et al.
American Heart Journal|December 9, 2003
Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyJ Bradley Oldemeyer, W Paul Biddle, Richard L Wurdeman, et al.
Pageof 10